182 related articles for article (PubMed ID: 32736780)
1. Thrombosis in hematological malignancies: mechanisms and implications.
Horowitz NA; Brenner B
Thromb Res; 2020 Jul; 191 Suppl 1():S58-S62. PubMed ID: 32736780
[TBL] [Abstract][Full Text] [Related]
2. Deep vein thrombosis: a less noticed complication in hematologic malignancies and immunologic disorders.
Alipanahzadeh H; Ghulamreza R; Shokouhian M; Bagheri M; Maleknia M
J Thromb Thrombolysis; 2020 Aug; 50(2):318-329. PubMed ID: 31808122
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic risk in hematological malignancies.
Franchini M
Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis and bleeding in hematological malignancy.
Wang TF; Leader A; Sanfilippo KM
Best Pract Res Clin Haematol; 2022 Mar; 35(1):101353. PubMed ID: 36030068
[TBL] [Abstract][Full Text] [Related]
5. Hematologic malignancies and thrombosis.
Elice F; Rodeghiero F
Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism and arterial complications.
Prandoni P; Piovella C; Pesavento R
Semin Respir Crit Care Med; 2012 Apr; 33(2):205-10. PubMed ID: 22648494
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis and hemostatic abnormalities in hematological malignancies.
Colombo R; Gallipoli P; Castelli R
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):441-50. PubMed ID: 25018062
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism incidence in hematologic malignancies.
Kekre N; Connors JM
Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
[TBL] [Abstract][Full Text] [Related]
9. Management of thrombosis in patients with hematologic malignancies.
Piccioli A; Vianello F; Prandoni P
Curr Hematol Rep; 2002 Sep; 1(1):79-83. PubMed ID: 12901128
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies.
Boersma RS; Jie KS; Verbon A; van Pampus EC; Schouten HC
Ann Oncol; 2008 Mar; 19(3):433-42. PubMed ID: 17962211
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism is associated with graft-
Kekre N; Kim HT; Ho VT; Cutler C; Armand P; Nikiforow S; Alyea EP; Soiffer RJ; Antin JH; Connors JM; Koreth J
Haematologica; 2017 Jul; 102(7):1185-1191. PubMed ID: 28341735
[TBL] [Abstract][Full Text] [Related]
12. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis.
Hsu C; Patell R; Zwicker JI
Blood Adv; 2023 Sep; 7(17):4721-4727. PubMed ID: 36170802
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review.
Krayem B; Brenner B; Horowitz NA
Semin Thromb Hemost; 2023 Jun; 49(4):348-354. PubMed ID: 36535649
[TBL] [Abstract][Full Text] [Related]
15. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
[TBL] [Abstract][Full Text] [Related]
16. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
17. PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count.
Scamuffa MC; Morano SG; Serrao A; Bruzzese A; Stocchi F; Santoro C; Vozella F; Latagliata R; Chistolini A
J Thromb Thrombolysis; 2020 Apr; 49(3):426-430. PubMed ID: 31981040
[TBL] [Abstract][Full Text] [Related]
18. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang TF; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R; Feng M; Simpson P; Billett HH
Thromb Res; 2021 Jun; 202():155-161. PubMed ID: 33862470
[TBL] [Abstract][Full Text] [Related]
19. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies.
Juhl RC; Roddy JVF; Wang TF; Li J; Elefritz JL
Leuk Lymphoma; 2018 Oct; 59(10):2377-2382. PubMed ID: 29424601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
